Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)
Open Access
- 6 January 2004
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 90 (1) , 87-92
- https://doi.org/10.1038/sj.bjc.6601462
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancerBritish Journal of Cancer, 2003
- Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized TrialJournal of Clinical Oncology, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 2001
- Phase II study of docetaxel and cisplatin in patients with previously untreated metastatic non-small-cell lung cancerInternational Journal of Clinical Oncology, 2000
- Phase I and Pharmacologic Study of Docetaxel and Irinotecan in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Randomized Trial of Paclitaxel Plus Supportive Care Versus Supportive Care for Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995